Friday's vital data: AAPL, GE, UAL >>> READ MORE

Study: Prilosec, Nexium, Prevacid May Lead to Heart Disease

The study finds that proton pump inhibitors may increase heart disease


pharma stockThe current issue of Circulation, the journal of the American Heart Association, claims that proton pump inhibitors (PPI) raises risk of heart attacks.

PPI’s are a type of drug that is used to suppress stomach acid, and includes AstraZeneca’s (AZN) Prilosec and Nexium, as well as Takeda Pharmaceutical’s (TKPYY) Prevacid, reports Forbes.

The study, by John P. Cooke, chair of the department of cardiovascular sciences at Houston Methodist Hospital, found that PPI’s led to a 25 percent increase in a chemical called ADMA, in both mice and human tissue, reports Forbes.

“Our work is consistent with previous reports that PPIs may increase the risk of a second heart attack in people that have been hospitalized with an acute coronary syndrome,” Cooke told Medical Xpress.

For a long time consuming omega-3 fatty acids has been recommended to increase heart health, but a recent study finds that it might not be a good idea for men.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC